Dr. Varmus is a professor at Weill Cornell Medicine. He shared the 1989 Nobel Prize in medicine for the discovery of cancer ...

The No. 2 in command at the National Institutes of Health, Dr. Lawrence A. Tabak, who served as acting director of the agency ...

Changes to a key funding formula will reduce research grants at hospitals and universities by billions — and may discourage ...

Here’s a look at what the Trump administration’s decision to cut overhead funding for biomedical research means for ...

The University of Iowa is in danger of losing out on $33.4 million in research funding if National Institutes of Health ...

Two key staff members at the National Institutes of Health (NIH) are reportedly leaving the agency amid ongoing efforts by ...

While the economic pain may not be as deeply felt as it might be at UAB and in Birmingham, NIH cuts will hurt UA and ...

Harvard researchers are facing uncertainty as the NIH’s proposed cuts to indirect funding could severely disrupt essential ...

The state's life sciences industry, which generated $3.3 billion in economic activity in 2023, could be severely impacted by ...

Dr. Lawrence A. Tabak, 73, has abruptly resigned from his post as acting director of the National Institutes of Health (NIH).

Private investment in pharmaceutical research can't replace the NIH. Both public investment and the private sector are needed ...

The University of Utah faces a potential loss of $43.5 million in NIH funding due to cuts proposed by the Trump ...